Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Canopy Growth

Canadian Marijuana Stocks To Add To Your July Watchlist The post Best Canadian Marijuana Stocks To Buy? 2 To Watch In July appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Marijuana Stocks To Buy? 2 To Watch In July

SNDL Inc.

Shares of Nasdaq-listed cannabis companies such as Tilray Inc. (NASDAQ:TLRY), Sundial Growers Inc. (NASDAQ:SNDL) and Aurora Cannabis Inc. (NASDAQ:ACB) have emerged as favorites of retail investors this year and continue to trend on Reddit's r/WallStreetBets forum, which has 10.6 million members and is known for short squeezes. Here's a comparative take on which retail-favorite cannabis stock gave the best returns in the first half of 2021.

Sundial Vs. Tilray Vs.

Aurora Cannabis

The Alternative Harvest exchange traded fund is up a healthy 38% year-to-date at $20.63. Over the past year, the ETF has risen 59%, outpacing broader stock markets.

3 Best Canadian Marijuana Stocks to Buy for the Upside Potential

While TLRY stock has now drawn attention from the Reddit crowd, insider selling makes banking on social media a tough proposition. The post Reddit's Relationship With Tilray May Not Be Lasting Love appeared first on InvestorPlace.

Reddit's Relationship With Tilray May Not Be Lasting Love

Cannabis giant Tilray, Inc. (NASDAQ:TLRY) announced on Wednesday that its SweetWater Brewing Company has launched its first Canadian craft cannabis brew in the US in collaboration with Canada's Broken Coast Cannabis Ltd. The tasty craft beer, Broken Coast BC Lager,  is the result of a collaboration between the Atlanta-based SweetWater –  acquired by Aphria Inc. (TSX:APHA) (NASDAQ:APHA) in November prior to the merger with Tilray – and Canada's leading craft cannabis brand under Tilray's portfolio in British Columbia.

Tilray Has Beer: Craft Cannabis Brew Coming Soon To US Bars and Stores

NEW YORK--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that its SweetWater Brewing Company (“SweetWater”) has launched a new product collaboration with Canada's leading craft cannabis brand Broken Coast Cannabis Ltd. (“Broken Coast”), a brand under the Tilray portfolio based in British Columbia and geared toward the premium cannabis market. “Broken Coast BC Lager1 ” is the first cross-bran

Tilray Introduces Its First Cross-brand Product Collaboration and Launches Canadian Craft Cannabis Brand, Broken Coast, in the U.S.

Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) released a proxy statement with an open letter from the company's CEO Irwin D. Simon, in which he called on shareholders to support a proposal to be discussed up at the upcoming annual shareholder meeting.

Tilray CEO Seeks Shareholder Approval For Dilution To Fuel Its Acquisitions Plans

Tilray Inc. (NASDAQ:TLRY) has convened a meeting with shareholders on 29th July seeking board approval on several strategic initiatives. The company wants to raise more capital by increasing authorised common stock to finance future acquisitions.

As Tilray targets more strategic acquisitions, is it time to buy?

Tilray Inc. Chief Executive Irwin Simon called on shareholders to support a proposal at the company's annual shareholder meeting that will allow the Canadian cannabis company to increase the number of authorized shares of common stock, enabling it to make acquisitions for growth. "Importantly, approval does not mean that the authorized shares will be issued, only that they are available if needed in pursuit of these important corporate initiatives to drive shareholder value,' Simon wrote in a letter to shareholders.

Tilray CEO seeks shareholder approval to increase stock and give it ammunition to make acquisitions

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today distributed a proxy statement, which included an open letter from Irwin D. Simon, Chairman and Chief Executive Officer of Tilray, to its stockholders seeking support for several important proposals to be voted on at the Special Meeting of Tilray stockholders, scheduled for July 29, 2021. Tilray is seeking to increase the nu

Tilray Asks Stockholders to Support Key Initiatives to Drive Strategic Growth and Strengthen Stockholder Rights

Village Farms International

Tilray is significantly bigger, but is it a better investment?

Better Cannabis Stock: Tilray vs. Village Farms

Mexco Energy (AMEX:MXC) shares closed up 14.1% at $10.28 Elixinol Wellness (OTC:ELLXF) shares closed up 10.29% at $0.11

Tilray, KushCo And Aurora Among Top Cannabis Stock Movers On June 28, 2021

Why Some Wall Street Analysts Think Tilray Stock Could Take Off

AFC Gamma

Arena Pharmaceuticals

Corbus Pharmaceuticals Holdings

Evogene

India Globalization Capital

OrganiGram Holdings Inc.

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues to take shape in 2021.

Pot Stocks in Focus: Cannabis-Based Pharmaceutical Trials

High Tide

High Tide adds another top e-commerce platform to its portfolio which will now include 3 out of the top 5 most popular e-commerce platforms for consumption accessories globally totaling 91 million site visits in 2020, including 23 million associated with Daily High Club alone. 1 High Tide gains access to Daily High Club's over 15,000 subscription box members who are ideal customers for High Tide to potentially launch cannabis subscription boxes in the event of U.S. federal legalization.

High Tide Continues to Expand U.S. E-Commerce Presence Through Acquisition of Daily High Club

Tilray Inc's (NASDAQ: TLRY) stock was flying higher on Thursday through a resistance level near the $17.50 area. A House committee on Thursday approved a funding bill with provisions that would protect banks from doing business with state-legal cannabis companies, which is a major hurdle when they try to grow their businesses.

Tilray Moves Higher, Options Traders Place Their Bets

The merger with Aphria has put this Canadian pot company on the map.

After the Merger With Aphria, Tilray Remains a Smart Buy

Cronos Group

The Small Exchange celebrated its one-year anniversary with the launch of the first futures contract on marijuana stocks. Small Cannabis, listed under the S420 symbol, is based on an index that includes 21 producers and distributors of medical and recreational cannabis products.

S420: The First Ever U.S. Cannabis Equity Index Future Contract

TLRY stock is inside a decent base for long-term success. Owning it now is smart, but it is best to leave room for error from market weakness.

Tilray Stock Is Budding and Is a Great Long-Term Buy

Aphria

The verdict is still out on this marijuana megamerger.

How Strong Is Tilray After the Aphria Merger?

For investors wanting to make a bet, investing in this company makes more sense.

Pass on Dogecoin! This Stock Is a Better Buy

HEXO Corp

Are These Canadian Cannabis Stocks A Buy At Current trading levels? The post Should You Be Buying Top Canadian Marijuana Stocks Right Now? 2 To Checkout This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Should You Be Buying Top Canadian Marijuana Stocks Right Now? 2 To Checkout This Week

TLRY stock soared and crashed due to a misguided short squeeze attempt. However, Tilray now has a real shot at turning the business around.

With Merger Complete, Here's Tilray's Roadmap to Profitability

Purple Innovation

The rise of the meme stocks in recent months has traders excited about investing their money and having it doubled, tripled, or even quadrupled in a matter of days. Many ships, however, including GameStop and AMC Entertainment, have already sailed.

The next two meme stocks to buy in July: Tilray and Purple Innovation

While TLRY stock has now drawn attention from the Reddit crowd, insider selling makes banking on social media a tough proposition. The post Buying Into Tilray Stock as a Meme Play Will Benefit the Wrong Side appeared first on InvestorPlace.

News for Tilray Brands Stock (TLRY)